Can Low Patient Days Affect Community Health (CYH) Q4 Earnings?
https://www.zacks.com/stock/news/2227012/can-low-patient-days-affect-community-health-cyh-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227012
Feb 15, 2024 - Community Health's (CYH) fourth-quarter results are likely to reflect lower adjusted admissions, declining beds in services and occupancy rate.
0
Higher Visits to Soften Cost Blow for Teladoc (TDOC) Q4 Earnings
https://www.zacks.com/stock/news/2227030/higher-visits-to-soften-cost-blow-for-teladoc-tdoc-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227030
Feb 15, 2024 - Teladoc's (TDOC) fourth-quarter results are likely to reflect growth in BetterHelp's profit levels.
0
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2229757/amedisys-amed-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2229757
Feb 21, 2024 - While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
AMED vs. USPH: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2230350/amed-vs-usph-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2230350
Feb 22, 2024 - AMED vs. USPH: Which Stock Is the Better Value Option?
0
Has AMETEK (AME) Outpaced Other Computer and Technology Stocks This Year?
https://www.zacks.com/stock/news/2233871/has-ametek-ame-outpaced-other-computer-and-technology-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2233871
Feb 29, 2024 - Here is how Ametek (AME) and HashiCorp, Inc. (HCP) have performed compared to their sector so far this year.
0
Will Ametek (AME) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2252142/will-ametek-ame-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2252142
Apr 08, 2024 - Ametek (AME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
Here's Why Hold Strategy is Apt for Antero Midstream (AM) Stock
https://www.zacks.com/stock/news/2252792/here-s-why-hold-strategy-is-apt-for-antero-midstream-am-stock?cid=CS-ZC-FT-analyst_blog|rank_focused-2252792
Apr 09, 2024 - Antero Midstream (AM) maintains a high ROIC, averaging 17% from 2020 to 2023, underscoring its effective use of capital in generating profits.
0
Antero Midstream (AM) Upgraded to Strong Buy: What Does It Mean for the Stock?
https://www.zacks.com/stock/news/2257926/antero-midstream-am-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2257926
Apr 18, 2024 - Antero Midstream (AM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
0
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2261798/compared-to-estimates-amedisys-amed-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2261798
Apr 24, 2024 - The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
https://www.zacks.com/stock/news/2261552/premium-growth-propels-humana-hum-to-easy-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2261552
Apr 24, 2024 - Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.
0